Erector Spina Plane (ESP) Block in Pediatric Patients

Evaluation of the Effect of Ultrasonographic Guided Erector Spina Plan Block Application on Postoperative Analgesia in Infants Undergoing Laparotomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04875390

Enrollment

Registered

2021-05-06

Start date

2021-05-10

Completion date

2022-07-18

Last updated

2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Postoperative Pain

Keywords

erector spina plane block, pediatric patient

Brief summary

In this study, we aimed to evaluate the erector spina plane (ESP) block method that we used in our clinic with ultrasonography in pediatric cases between 1 month and 2 years of age who underwent laparotomy.

Detailed description

36 patients who will undergo laparotomy between the ages of 1 month and 2 years in ASA ( American Society of Anesthesiologists) I-II class will be included in the study. patients will be divided into 2 groups. Intraoperative erector spina plane block will be applied to the 1st group (group E) and intraoperative local anesthetic infiltration will be applied to the 2nd group (group L). Postoperative pain will be evaluated with the FLACC (face, legs, activity, crying, consolation) scale.

Interventions

OTHERErector spina plane block

After the surgery is completed, intraoperative Erector spina plane block will be performed

OTHERlocal infiltration

After the surgery is completed, intraoperative local infiltration will be performed

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

1 Months to 2 Years

Healthy volunteers

Inclusion criteria

* 1 month and 2 years of age * ASA (American Society of Anesthesiologists) I-II class * Patients who underwent nephrectomy, pyeloplasty, adrenal tumor excision with unilateral paramedian incision

Exclusion criteria

* Patients who underwent laparotomy with a midline incision * Local infection at the injection site, * Anatomical anomalies * Allergies to local anesthetics, * Coagulopathy, * Liver, kidney failure patients

Design outcomes

Primary

Measure	Time frame	Description
the 6th hour pediatric pain scale, face ,legs , activity; cry;consolability (FLACC)	6th hour	FLACC : Each of the five categories (F)face; (L)legs; (A)activity; (C)cry; (C)consolability is scored from 0-2 which results in a total score between 0 and 10. 0:relaxed and comfortable, 1-3: mild discomfortable, 4-6: moderate pain, 7-10: severe pain

Secondary

Measure	Time frame	Description
paracetamol consumption	24 hours	the total number of paracetamol requirements in the first 24 hours in all patients

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026